Table 3 Clinical and functional characteristics, by age and severity of obstruction.
ATS/ERS stage | |||
|---|---|---|---|
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 47.3 | 58.1 | 65.9 |
Ischemic heart disease (%)1 | 21.6 | 23.1 | 25.6 |
Cerebro-vascular disease (%) | 11.0 | 5.6 | 4.4 |
Diabetes (%) | 15.9 | 15.4 | 16.7 |
Cancer (%) | 8.2 | 8.8 | 4.4 |
6MWD % predicted (mean [SD]) | 76.8 (30.5) | 78.1 (24.7) | 66.2 (24.9) |
GDS score (mean [SD]) | 4.2 (3.3) | 3.6 (3.4) | 4.5 (3.5) |
MMSE score (mean [SD]) | 26.5 (3.7) | 26.4 (4.2) | 25.3 (4.8) |
Barthel Index (mean [SD]) | 92.8 (9.6) | 92.6 (12.4) | 91.0 (10.9) |
BTS stage | |||
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 47.3 | 66.7 | 74.2 |
Ischemic heart disease (%)1 21.9 | 24.5 | 25.8 | |
Cerebro-vascular disease (%) | 10.0 | 5.3 | 3.2 |
Diabetes (%) | 16.6 | 16.0 | 9.7 |
Cancer (%) | 8.3 | 6.4 | 3.2 |
6MWD % predicted (mean [SD]) | 78.9 (29.0) | 69.9 (24.0)1 | 57.8 (26.8) |
GDS score (mean [SD]) | 4.0 (3.3) | 4.2 (3.5) | 5.2 (4.1) |
MMSE score (mean [SD]) | 26.5 (3.8) | 25.6 (4.6)1 | 25.6 (4.5) |
Barthel Index (mean [SD]) | 92.9 (10.3) | 91.7 (9.9) | 89.7 (14.1) |
GOLD stage | |||
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 42.7 | 57.3 | 68.5 |
Ischemic heart disease (%)1 | 22.3 | 21.0 | 24.8 |
Cerebro-vascular disease (%) | 11.2 | 7.4 | 4.8 |
Diabetes (%) | 16.5 | 16.8 | 14.4 |
Cancer (%) | 7.8 | 9.5 | 5.6 |
6MWD % predicted (mean [SD]) | 81.3 (29.4) | 75.2 (28.0) | 66.8 (25.1) |
GDS score (mean [SD]) | 4.1 (3.6) | 3.6 (3.3) | 4.4 (3.7) |
MMSE score (mean [SD]) | 26.7 (3.6) | 26.1 (4.3) | 25.6 (4.5) |
Barthel Index (mean [SD]) | 93.3 (9.3) | 92.1 (12.2) | 91.2 (11.0) |